Therapy Insight: The changing spectrum of rheumatic disease in HIV infection

Nature Clinical Practice Rheumatology

Volumn 4, Issue 8, 2008, Pages 428-438

  Maganti, Rashmi M ^a   Reveille, John D ^a   Williams, Frances M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; BISPHOSPHONIC ACID DERIVATIVE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROTEINASE INHIBITOR; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTHRITIS; AVASCULAR NECROSIS; BEHCET DISEASE; BONE DISEASE; BONE INFECTION; CLINICAL FEATURE; CRYOGLOBULINEMIA; CYTOKINE PRODUCTION; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; DUPUYTREN CONTRACTURE; EPIDEMIC; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMEROSCAPULAR PERIARTHRITIS; HYPERGAMMAGLOBULINEMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPETENCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LIPOMATOSIS; LOW DRUG DOSE; LYMPHOCYTOSIS; LYMPHOMA; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOSITIS; OSTEOLYSIS; OSTEOMYELITIS; OSTEOPENIA; OSTEOPOROSIS; PAIN; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SIDE EFFECT; SPONDYLOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPOROMANDIBULAR JOINT DISORDER; TENOSYNOVITIS; THROMBOCYTOPENIA; VASCULITIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOIMMUNE DISEASES; HIV INFECTIONS; HUMANS; RHEUMATIC DISEASES;

EID: 48749085404     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0836     Document Type: Review

References (64)

1. WHO publication ISBN 9291735426. AIDS Epidemic Update: December 2006 [http://www.who.int/hiv/pub/epidemiology/epiupdate2006/en/index.html] (accessed 6 May 2008)
2. Winchester R et al. (1987) The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 106: 19-26
3. Zandman-Goddard G and Shoenfeld Y (2002) HIV and autoimmunity. Autoimmun Rev 1: 329-337
4. Sempere JM et al. (2007) T regulatory cells and HIV infection. AIDS Rev 9: 54-60
5. Chinniah K et al. (2005) Arthritis in association with human immunodeficiency virus infection in black African children: Causal or coincidental? Rheumatology (Oxford) 44: 915-920
6. Njobvu PD and McGill PE (1999) Is HIV the culprit? Spondyloarthropathy in the Third World. J Rheumatol 26: 2074-2075
7. Reveille JD et al. (1990) Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: A disease continuum? Arthritis Rheum 33: 1574-1578
8. Njobvu P and McGill P (2005) Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol 32: 1299-1304
9. Gherardi RK (1994) Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 20: 232-237
10. Johnson RW et al. (2003) Human immunodeficiency virus-associated polymyositis: A longitudinal study of outcome. Arthritis Rheum 49: 172-178
11. Williams FM et al. (1998) Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 41: 863-868
12. Itescu S et al. (1989) A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 2: 466-468
13. Moulignier A et al. (1997) Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 41: 438-445
14. Authier FJ and Gherardi RK (2006) Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy [French]. Rev Neurol (Paris) 162: 71-81
15. Schiodt M (1992) HIV-associated salivary gland disease: A review. Oral Surg Oral Med Oral Pathol 73: 164-167
16. Basu D et al. (2006) Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 55: 466-472
17. Itescu S et al. (1993) Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest 91: 2216-2225
18. Itescu S (1991) Diffuse infiltrative lymphocytosis syndrome in human immunodeficiency virus infection - a Sjögren's-like disease. Rheum Dis Clin North Am 17: 99-115
19. Guillevin L et al. (1997) The spectrum and treatment of virus-associated vasculitides. Curr-Opin Rheumatol 9: 31-36
20. Chetty R et al. (2000) Large artery vasculopathy in HIV-positive patients: Another vasculitic enigma. Hum Pathol 31: 374-379
21. Velez AP et al. (2006) Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patients. AIDS Read 16: 464-466
22. + T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin Diagn Lab Immunol 6: 105-114
23. Nguyen H et al. (2005) Churg-Strauss syndrome associated with HIV Infection. J Am Board Fam Pract 18: 140-142
24. Hidaka H et al. (2003) Henoch-Schönlein purpura nephritis in a patient infected with the human immunodeficiency virus [Japanese]. Nippon Jinzo Gakkai Shi 45: 387-392
25. Cicalini S et al. (2004) Remission of Behçet's disease and keratoconjunctivitis sicca in an HIV-infected patient treated with HAART. Int J STD AIDS 15: 139-140
26. Gomez-Puerta JA et al. (2006) Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy. Isr Med Assoc J 8: 513-514
27. Sekigawa I et al. (2002) Lessons from similarities between SLE and HIV infection. J Infect 44: 67-72
28. Ornstein MH et al. (1995) A reexamination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis Rheum 38: 1701-1706
29. Munoz FS et al. (1991) Osteoarticular infection associated with the human immunodeficiency virus. Clin Exp Rheumatol 9: 489-493
30. Hirsch R et al. (1996) Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. Semin Arthritis Rheum 25: 347-356
31. Jellis JE (2002) Human immunodeficiency virus and osteoarticular tuberculosis. Clin Orthop Relat Res 398: 27-31
32. Rajeswaran G et al. (2006) The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: Appearances in 11 patients. Clin Radiol 61: 833-843
33. Calabrese LH et al. (2005) Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: Emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35: 166-174
34. Helbert M et al. (1988) Zidovudine-associated myopathy. Lancet 2: 689-690
35. Florence E et al. (2002) Rheumatological complications associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis 61: 82-84
36. Tebas P et al. (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14: F63-F67
37. Sighinolfi L et al. (2000) Avascular necrosis of the femoral head: a side effect of highly active antiretroviral therapy (HAART) in HIV patients? Infection 28: 254-255
38. Falco M et al. (1993) Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome. Ann Ital Med Int 8: 171-174
39. Kosmas N et al. (2006) Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients. J Med Virol 78: 1257-1261
40. Klaassen RJ et al. (1992) Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87: 24-30
41. Price P et al. (2001) Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 22: 279-287
42. French MA and Price P (2001) Immune restoration disease in HIV-infected patients after antiretroviral therapy. Clin Infect Dis 32: 325-326
43. Shelburne SA III et al. (2002) Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-227
44. French MA et al. (2004) Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: Evidence of thymic dysfunction. AIDS Res Hum Retroviruses 20: 157-162
45. Bourinbaiar AS and Lee-Huang S (1995) The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Lett 360: 85-88
46. Disla E et al. (1994) Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine. J Rheumatol 21: 662-664
47. Chiang G et al. (1996) Inhibition of HIV-1 replication by hydroxychloroquine: Mechanism of action and comparison with zidovudine. Clin Ther 18: 1080-1092
48. McComsey GA et al. (2001) Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS 15: 321-327
49. -3. J Acquir Immune Defic Syndr 32: 281-286
50. Sha BE et al. (2002) Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses 18: 661-665
51. Kaur PP et al. (2007) Successful etanercept use in an HIV-positive patient with rheumatoid arthritis. J Clin Rheumatol 13: 79-80
52. Aboulafia DM et al. (2000) Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc 75: 1093-1098
53. Gaylis N (2003) Infliximab in the treatment of an HIV positive patient with Reiter's syndrome. J Rheumatol 30: 407-411
54. Bartke U et al. (2004) Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br J Dermatol 150: 784-786
55. Beltran B et al. (2006) Safe and effective application of anti-TNF-α in a patient infected with HIV and concomitant Crohn's disease. Gut 55: 1670-1671
56. Ahmad HN et al. (2004) Rituximab in chronic, recurrent HIV-associated immune thrombocytopenic purpura. Br J Haematol 127: 607-608
57. Schneider J and Zatarain E (2006) IRIS and SLE. Clin Immunol 118: 152-153
58. Diri E et al. (2000) Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 27: 2711-2714
59. Drake WP et al. (2003) Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome. J Clin Rheumatol 9: 176-180
60. Calza L et al. (2003) Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 14: 356-359
61. Calza L et al. (2004) Polymyositis associated with HIV infection during immune restoration induced by highly active anti-retroviral therapy. Clin Exp Rheumatol 22: 651-652
62. Sellier P et al. (2000) Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy. Am J Med 109: 510-512
63. Wegrzyn J et al. (2002) Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: Possible contribution of tritherapy. J Rheumatol 29: 2232-2234
64. Bell C et al. (2002) A case of immune reconstitution rheumatoid arthritis. Int J STD AIDS 13: 580-581